{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:42:39Z","timestamp":1789508559036,"version":"build-2803163510"},"reference-count":95,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychol."],"abstract":"<jats:p>This article investigates the novel therapeutic approach of \u201camplified psychoanalysis\u201d through a detailed examination of the Ygg case, which offers a descriptive single-case illustration of the integration of MDMA-assisted therapy with traditional psychoanalytic treatment for obsessive-compulsive disorder (OCD). The study explores how subjective experience induced by MDMA can interact with an ongoing analysis, potentially enhancing psychoanalytic processes by facilitating access to unconscious material and helping to move beyond therapeutic impasses. The work is presented as a psychoanalytic single-case clinical narrative, acknowledging the value of such cases for generating nuanced insights into psychological phenomena rather than for demonstrating efficacy. In this case, the integration of MDMA experiences within an established psychoanalytic framework appeared to create specific therapeutic opportunities: the altered states of consciousness were experienced by the patient as allowing more direct access to, and processing of, previously avoided memories and affects. This combination may be particularly promising for OCD, where traditional approaches often face limitations; however, its efficacy requires systematic investigation beyond this psychoanalytic single-case clinical narrative. The clinical process analysis highlights several putative processes of change, including enhanced emotional processing, a strengthened therapeutic alliance, and improved access to traumatic memories. The study aims to contribute to both psychedelic therapy and psychoanalytic practice by offering a novel therapeutic perspective on the treatment of OCD. It suggests that \u201camplified psychoanalysis\u201d may represent a promising direction for future research with larger samples and formal outcome measures.<\/jats:p>","DOI":"10.3389\/fpsyg.2026.1617428","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:52:54Z","timestamp":1773211974000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: Amplified psychoanalysis? Psychoanalysis, OCD and MDMA in a clinical case study"],"prefix":"10.3389","volume":"17","author":[{"given":"Filippo","family":"Dellanoce","sequence":"first","affiliation":[{"name":"Laboratoire Interdisciplinaire R\u00e9cits Cultures Et Soci\u00e9t\u00e9s (LIRCES EA 3159), Member SIMEPSI (Italian Society for Psychedelic Medicine), Universit\u00e9 Nice-Sophia Antipolis","place":["Nice, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"B1","article-title":"Through the gateway of the heart","volume-title":"Accounts of Experiences with MDMA and Other Empathogenic Substances","author":"Adamson","year":"2012"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1529427","DOI":"10.3389\/fpsyt.2025.1529427","article-title":"Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: A novel theoretical approach.","volume":"16","author":"Albert","year":"2025","journal-title":"Front. Psychiatry"},{"key":"B3","volume-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR, G - Reference, Information and Interdisciplinary Subjects Series.","year":"2022"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1101\/021329","article-title":"Effects of MDMA on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting.","author":"Baggott","year":"2015","journal-title":"bioRxiv[Preprint]"},{"key":"B5","doi-asserted-by":"publisher","first-page":"109735","DOI":"10.1016\/j.pnpbp.2019.109735","article-title":"Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis.","volume":"96","author":"Bahji","year":"2020","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B6","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/10481885.2022.2106141","article-title":"Psychedelic psychodynamics: Relational knowing and the unthought known.","volume":"32","author":"Barrett","year":"2022","journal-title":"Psychoanal. Dialogues"},{"key":"B7","doi-asserted-by":"publisher","first-page":"824077","DOI":"10.3389\/fpsyg.2022.824077","article-title":"Psychedelic integration: An analysis of the concept and its practice.","volume":"13","author":"Bathje","year":"2022","journal-title":"Front. Psychol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00213-009-1635-z","article-title":"Effects of MDMA on sociability and neural response to social threat and social reward.","volume":"207","author":"Bedi","year":"2009","journal-title":"Psychopharmacology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1177\/0269881116663120","article-title":"The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?","volume":"30","author":"Bershad","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"B10","volume-title":"Learning From Experience, Routledge Classics.","author":"Bion","year":"1962"},{"key":"B11","volume-title":"Elements of Psychoanalysis.","author":"Bion","year":"1963"},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.4324\/9780203069547","volume-title":"Catch Them Before They Fall: The Psychoanalysis of Breakdown.","author":"Bollas","year":"2012"},{"key":"B13","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1177\/0269881120926673","article-title":"Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experiment.","volume":"35","author":"Borissova","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s40263-020-00748-y","article-title":"Psychedelic treatments for psychiatric disorders: A systematic review and thematic synthesis of patient experiences in qualitative studies.","volume":"34","author":"Breeksema","year":"2020","journal-title":"CNS Drugs"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1232459","DOI":"10.3389\/fnins.2023.1232459","article-title":"The ego in psychedelic drug action \u2013 ego defenses, ego boundaries, and the therapeutic role of regression.","volume":"17","author":"Buchborn","year":"2023","journal-title":"Front. Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"13378","DOI":"10.1038\/s41598-023-39812-0","article-title":"Improvement in OCD symptoms associated with serotoninergic psychedelics : A retrospective online survey","volume":"13","author":"Buot","year":"2023","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/brain\/awq010","article-title":"The default-mode, ego-functions and free-energy: A neurobiological account of Freudian ideas.","volume":"133","author":"Carhart-Harris","year":"2010","journal-title":"Brain J. Neurol."},{"key":"B18","volume-title":"Le cas Paramord : Obsession et contrainte psychique, aujourd\u2019hui","author":"Castel","year":"2016"},{"key":"B19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1176\/appi.psychotherapy.2009.63.3.245","article-title":"Is a psychodynamic perspective relevant to the clinical management of obsessive-compulsive disorder?","volume":"63","author":"Chlebowski","year":"2009","journal-title":"Am. J. Psychother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1752-0118.2000.tb00537.x","article-title":"Obsessional thinking - A defence against loss.","volume":"16","author":"Cooper","year":"2000","journal-title":"Br. J. Psychother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1177\/0269881106063271","article-title":"A review of acute effects of 3,4-methylenedioxymeth-amphetamine in healthy volunteers.","volume":"20","author":"Dumont","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/17470910802649470","article-title":"Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration.","volume":"4","author":"Dumont","year":"2009","journal-title":"Soc. Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/00005053-195812000-00006","article-title":"Psychotherapy with lysergic acid diethylamide","volume":"127","author":"Eisner","year":"1958","journal-title":"J. Nerv. Ment. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1177\/000306518903700203","article-title":"Psychoanalysis and general psychiatry: Obsessive-compulsive disorder as paradigm.","volume":"37","author":"Esman","year":"1989","journal-title":"J. Am. Psychoanal. Assoc."},{"key":"B25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/07351692109348929","article-title":"Obsessive-compulsive disorder: Current views.","volume":"21","author":"Esman","year":"2001","journal-title":"Psychoanal. Inq."},{"key":"B26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.pnpbp.2018.03.003","article-title":"MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?","volume":"84","author":"Feduccia","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-75393-1","volume-title":"The Neurobiology and Treatment of OCD: Accelerating Progress","author":"Fineberg","year":"2021"},{"key":"B28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jbtep.2006.12.001","article-title":"Metacognitive therapy for obsessive\u2013compulsive disorder: A case series.","volume":"39","author":"Fisher","year":"2008","journal-title":"J. Behav. Ther. Exp. Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00213-002-1071-9","article-title":"Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA (\u201cecstasy\u201d) polydrug users.","volume":"162","author":"Fox","year":"2002","journal-title":"Psychopharmacology"},{"key":"B30","first-page":"116","article-title":"Obsessional neurosis: A summary of psycho-analytic views as presented at the Congress.","volume":"47","author":"Freud","year":"1966","journal-title":"Int. J. Psychoanal."},{"key":"B31","volume-title":"The Interpretation of Dreams.","author":"Freud","year":"1900"},{"key":"B32","first-page":"151","article-title":"Notes upon a case of obsessional neurosis","volume-title":"Two Case Histories (\u2018Little Hans\u2019 and the \u2018Rat Man\u2019), The Standard Edition of the Complete Psychological Works of Sigmund Freud","author":"Freud","year":"1909"},{"key":"B33","first-page":"1914","article-title":"Papers on metapsychology","volume-title":"On the History of the Psycho-Analytic Movement, Papers on Metapsychology and Other Works, The Standard Edition of the Complete Psychological Works of Sigmund Freud","author":"Freud","year":"1915"},{"key":"B34","volume-title":"Les Entretiens Pr\u00e9liminaires \u00e0 une Psychanalyse.","author":"Freymann","year":"2016"},{"key":"B35","first-page":"41","volume-title":"3. La N\u00e9vrose Obsessionnelle est-elle Synonyme des \u00ab Tocs \u00bb?, in: L\u2019inconscient, Pour Quoi Faire?.","author":"Freymann","year":"2018"},{"key":"B36","volume-title":"Psychodynamic Psychiatry in Clinical Practice","author":"Gabbard","year":"2014"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/h0086822","article-title":"Bridging the gap between biological and psychological perspectives in the treatment of anxiety disorders","volume":"40","author":"Gauthier","year":"1999","journal-title":"Can. Psychol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2024.2405685","article-title":"Going underground: Demographics, services, and best practices endorsed by practitioners providing support for naturalistic psychedelic use.","author":"Glynos","year":"2024","journal-title":"J. Psychoactive Drugs"},{"key":"B39","volume-title":"LSD Psychotherapy","author":"Grof","year":"1980"},{"key":"B40","volume-title":"The Way of the Psychonaut : Encyclopedia for Inner Journeys","author":"Grof","year":"2019"},{"key":"B41","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.pbb.2007.10.003","article-title":"Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons.","volume":"90","author":"Gudelsky","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B42","first-page":"726","article-title":"Contemporary Reflections on Hysterical and Obsessive Neurosis.","volume":"4","author":"Henrique","year":"2014","journal-title":"J. Psychol. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41386-019-0569-3","article-title":"Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects.","volume":"45","author":"Holze","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3917\/enje.028.0099","article-title":"Passions et d\u00e9sir.","volume":"28","author":"Izcovich","year":"2017","journal-title":"Len-Je Lacanien"},{"key":"B45","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1600-0447.1964.tb04950.x","article-title":"Three years\u2019 experience with the use of LSD as an aid in psychotherapy","volume":"39","author":"Johnsen","year":"1964","journal-title":"Acta Psychiatr. Scand."},{"key":"B46","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/978-1-60761-792-1_27","article-title":"Single-case research: The German specimen case Amalia X","volume-title":"Psychodynamic Psychotherapy Research: Evidence-Based Practice and Practice-Based Evidence","author":"K\u00e4chele","year":"2012"},{"key":"B47","doi-asserted-by":"publisher","first-page":"800072","DOI":"10.3389\/fpsyt.2021.800072","article-title":"Psychedelic therapy\u2019s transdiagnostic effects: A Research Domain Criteria (RDoC) perspective.","volume":"12","author":"Kelly","year":"2021","journal-title":"Front. Psychiatry"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e12135","DOI":"10.1016\/j.heliyon.2022.e12135","article-title":"Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder : A case report","volume":"8","author":"Kelmendi","year":"2022","journal-title":"Heliyon"},{"key":"B49","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1521\/bumc.2007.71.4.291","article-title":"Psychodynamic and cognitive\u2013behavioral approaches of obsessive\u2013compulsive disorder: Is it time to work through our ambivalence?","volume":"71","author":"Kempke","year":"2007","journal-title":"Bull. Menninger Clin."},{"key":"B50","article-title":"Psychodynamic perspectives on OCD","volume-title":"Obsessive-compulsive Disorder : Phenomenology, Pathophysiology, and Treatment","author":"King","year":"2017"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1038\/npp.2014.12","article-title":"Effects of MDMA and intranasal oxytocin on social and emotional processing.","volume":"39","author":"Kirkpatrick","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"661233","DOI":"10.3389\/fpsyt.2021.661233","article-title":"Does psychedelic therapy have a transdiagnostic action and prophylactic potential?","volume":"12","author":"Ko\u010d\u00e1rov\u00e1","year":"2021","journal-title":"Front. Psychiatry"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1080177","DOI":"10.3389\/fnhum.2023.1080177","article-title":"Converging theories on dreaming: Between Freud, predictive processing, and psychedelic research.","volume":"17","author":"Koslowski","year":"2023","journal-title":"Front. Hum. Neurosci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/ijnp\/pyaa018","article-title":"Reviewing the potential of psychedelics for the treatment of PTSD.","volume":"23","author":"Krediet","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B55","volume-title":"The Seminar of Jacques Lacan, Book VI, 1958-1959, Desire and its Interpretation.","author":"Lacan","year":"1958"},{"key":"B56","volume-title":"Autres \u00c9crits, Champ Freudien.","author":"Lacan","year":"2001"},{"key":"B57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1037\/1541-1559.2.2.91","article-title":"Intensive cognitive behavioral therapy for pediatric obsessive compulsive disorder : A treatment protocol for mental health providers","volume":"2","author":"Lewin","year":"2005","journal-title":"Psychol. Serv."},{"key":"B58","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1556\/2054.2024.00373","article-title":"Psychedelics and psychoanalysis: The journey from talking cure to transformation.","volume":"9","author":"Lichtenstein","year":"2024","journal-title":"J. Psychedelic Stud."},{"key":"B59","doi-asserted-by":"crossref","first-page":"171","DOI":"10.71101\/rtp.47.70","article-title":"Neurose obsessiva ou TOC?","volume":"47","author":"Lima","year":"2015","journal-title":"Tempo Psicanalitico"},{"key":"B60","doi-asserted-by":"publisher","first-page":"733893","DOI":"10.3389\/fpsyt.2021.733893","article-title":"MDMA-assisted therapy as a means to alter affective, cognitive, behavioral, and neurological systems underlying social dysfunction in social anxiety disorder.","volume":"12","author":"Luoma","year":"2021","journal-title":"Front. Psychiatry"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e2824","DOI":"10.1002\/hup.2824","article-title":"Potential processes of change in MDMA-Assisted therapy for social anxiety disorder: Enhanced memory reconsolidation, self-transcendence, and therapeutic relationships.","volume":"37","author":"Luoma","year":"2021","journal-title":"Hum. Psychopharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1000456","DOI":"10.35248\/2161-0487.23.13.456","article-title":"Psychoanalytic formulations in psychedelic therapy for Treatment Resistant Depression (TRD).","volume":"13","author":"Maggio","year":"2023","journal-title":"J. Psychol. Psychother."},{"key":"B63","volume-title":"Psychoanalytic Diagnosis : Understanding Personality Structure in the Clinical Process","author":"McWilliams","year":"2011"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3389\/fpsyg.2017.01749","article-title":"Beyond clinical case studies in psychoanalysis: A review of psychoanalytic empirical single case studies published in ISI-ranked journals.","volume":"8","author":"Meganck","year":"2017","journal-title":"Front. Psychol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3917\/lcdd.097.0101","article-title":"L\u2019inconscient \u00e0 venir.","volume":"97","author":"Miller","year":"2017","journal-title":"Cause D\u00e9sir"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1038\/s41591-021-01526-z","article-title":"Reply to: Caution at psychiatry\u2019s psychedelic frontier and challenges with benchmarking of MDMA-assisted psychotherapy.","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat. Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1038\/s41591-023-02565-4","article-title":"MDMA-assisted therapy for moderate to severe PTSD: A randomized, placebo-controlled phase 3 trial.","volume":"29","author":"Mitchell","year":"2023","journal-title":"Nat. Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/0269881110378371","article-title":"The safety and efficacy of +\/- 3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: The first randomized controlled pilot study.","volume":"25","author":"Mithoefer","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/0269881112456611","article-title":"Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: A prospective long-term follow-up study.","volume":"27","author":"Mithoefer","year":"2013","journal-title":"J. Psychopharmacol. Oxf. Engl."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"B71","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s44159-022-00127-y","article-title":"Single case studies are a powerful tool for developing, testing and extending theories.","volume":"1","author":"Nickels","year":"2022","journal-title":"Nat. Rev. Psychol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1427531","DOI":"10.3389\/fpsyg.2024.1427531","article-title":"The conceptual framework for the therapeutic approach used in phase 3 trials of MDMA-assisted therapy for PTSD.","volume":"15","author":"O\u2019Donnell","year":"2024","journal-title":"Front. Psychol."},{"key":"B73","unstructured":"Oded\n              A.\n            \n          \n          Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe OCD\n          \n          2022"},{"key":"B74","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1177\/0269881120920420","article-title":"Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy.","volume":"35","author":"Oeri","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1177\/0269881118806297","article-title":"3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.","volume":"32","author":"Ot\u2019alora","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hup.2318","article-title":"Human psychobiology of MDMA or \u2018Ecstasy\u2019: An overview of 25 years of empirical research.","volume":"28","author":"Parrott","year":"2013","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2050324518767442","DOI":"10.1177\/2050324518767442","article-title":"The early use of MDMA (\u2018Ecstasy\u2019) in psychotherapy (1977\u20131985).","volume":"4","author":"Passie","year":"2018","journal-title":"Drug Sci. Policy Law"},{"key":"B78","first-page":"61","article-title":"Unacceptable obsessional thoughts and covert rituals","volume-title":"Clinical Handbook of Obsessive-Compulsive Disorder and Related Problems","author":"Purdon","year":"2008"},{"key":"B79","volume-title":"Jacques Lacan. Vol. 1: Desiderio, Godimento e Soggettivazione, Saggi.","author":"Recalcati","year":"2012"},{"key":"B80","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1080\/10481885.2022.2107855","article-title":"Introduction to the symposium on psychedelics and psychoanalysis: A conversation long overdue.","volume":"32","author":"Ringstrom","year":"2022","journal-title":"Psychoanal. Dialogues"},{"key":"B81","doi-asserted-by":"publisher","first-page":"S647","DOI":"10.1192\/j.eurpsy.2022.1659","article-title":"Therapeutic potential of serotoninergic psychedelic substances in the treatment of Obsessive Compulsive Disorder","volume":"65","author":"Rodrigues","year":"2022","journal-title":"Eur. Psychiatry"},{"key":"B82","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.euroneuro.2017.10.013","article-title":"Can exposure-based CBT extend the effects of intravenous ketamine in obsessive-compulsive disorder ? An open-label trial","volume":"28","author":"Rodriguez","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/10481885.2022.2106139","article-title":"Psychedelic psychoanalysis: Transformations of the self.","volume":"32","author":"Rundel","year":"2022","journal-title":"Psychoanal. Dialogues"},{"key":"B84","first-page":"53","article-title":"Psychoanalytic therapy of the obsessional patient","volume":"22","author":"Salzman","year":"1983","journal-title":"Curr. Psychiatr. Ther."},{"key":"B85","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1177\/0269881114542454","article-title":"Differential effects of MDMA and methylphenidate on social cognition.","volume":"28","author":"Schmid","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fpsyt.2019.00138","article-title":"A review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy.","volume":"10","author":"Sessa","year":"2019","journal-title":"Front. Psychiatry"},{"key":"B87","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/01062301.2024.2435736","article-title":"Transference, transformation, and transmission: Some clinical and conceptual issues.","volume":"47","author":"St\u00e4nicke","year":"2024","journal-title":"Scand. Psychoanal. Rev."},{"key":"B88","volume-title":"The Secret Chief Revealed.","author":"Stolaroff","year":"2004"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e15070","DOI":"10.7759\/cureus.15070","article-title":"The efficacy of MDMA (3,4-Methylenedioxymethamphetamine) for post-traumatic stress disorder in humans: A systematic review and meta-analysis.","volume":"13","author":"Tedesco","year":"2021","journal-title":"Cureus"},{"key":"B90","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1007\/s00213-014-3570-x","article-title":"MDMA alters emotional processing and facilitates positive social interaction.","volume":"231","author":"Wardle","year":"2014","journal-title":"Psychopharmacology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1017\/S0033291723001514","article-title":"Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.","volume":"54","author":"Weiss","year":"2024","journal-title":"Psychol. Med."},{"key":"B92","volume-title":"Metacognitive Therapy for Anxiety and Depression.","author":"Wells","year":"2011"},{"key":"B93","first-page":"149","article-title":"Obsessive-compulsive disorder ? Or, a narcissistic solution in an obsessional man?? A nineteen-year treatment in progress","volume":"4","author":"Willick","year":"1995","journal-title":"J. Clin. Psychoanal."},{"key":"B94","doi-asserted-by":"publisher","first-page":"20442","DOI":"10.1038\/s41598-020-75706-1","article-title":"MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: A randomized pilot study.","volume":"10","author":"Wolfson","year":"2020","journal-title":"Sci. Rep."},{"key":"B95","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1521\/pdps.2017.45.2.237","article-title":"An integrative approach to treatment-resistant obsessive-compulsive disorder","volume":"45","author":"Woon","year":"2017","journal-title":"Psychodyn. Psychiatry"}],"container-title":["Frontiers in Psychology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyg.2026.1617428\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:53:00Z","timestamp":1773211980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyg.2026.1617428\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":95,"alternative-id":["10.3389\/fpsyg.2026.1617428"],"URL":"https:\/\/doi.org\/10.3389\/fpsyg.2026.1617428","relation":{},"ISSN":["1664-1078"],"issn-type":[{"value":"1664-1078","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"article-number":"1617428"}}